drugset / Trial / NCT00712868

Acceptability of Lactacyd Femina

NCT00712868

Phase 4 Completed 559 enrolled Sanofi
NaSingle-groupOpen-labelTreatment

Summary

To demonstrate the safety and acceptability of the gynaecological formulation.

Timeline

Start
2008-06
Primary completion
2008-08
Completion
2008-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Lactic Acid Other / unclassified

Indications

No indication recorded.